Features
After nearly two years of bringing drugs to market amid a global pandemic, and before the true extent of the impending financial...
The swift development of the COVID-19 vaccine spawned an array of concerns for populations across the world. Lilly Subbotin explores these...
Kat Jenkins takes a look at the exciting research currently underway using AI, exploring what the future could hold for the complex field...
The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp of a breakthrough in oncology. Kat...
Several pharmaceutical firms have lately been fined for unfairly hiking prices over the years, meaning that patients and the NHS have suffered....
In it’s simplest form, drug repurposing is all about finding new therapeutic uses for existing drugs. Lilly Subbotin delves into the...
It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare industry has been immense. Now...
Lilly Subbotin explores clinical trial data and diversity to discover how the COVID-19 pandemic has highlighted the need for greater...
The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new...